ArticlePloS one2025

A novel sulfamoylphenyl-dihydro-thiadiazole derivative as a dual EGFR and carbonic anhydrase inhibitor for cancer therapy.

Ibrahim H Eissa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.